Simrat Randhawa
Chief Tech/Sci/R&D Officer chez DIANTHUS THERAPEUTICS, INC.
Fortune : 120 000 $ au 31/03/2024
Profil
Simrat Randhawa is currently the Chief Medical Officer at Dianthus Therapeutics, Inc. Prior to this, he held the position of Head-Medical Affairs at BioMarin Pharmaceutical, Inc. He also served as the Senior Vice President-Clinical & Medical Affairs at Aurinia Pharmaceuticals, Inc. from 2019 to 2022.
Dr. Randhawa holds an MBA from The Trustees of Columbia University in The City of New York and a doctorate from Drexel University College of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 4 000 ( 0,01% ) | 120 000 $ | 31/03/2024 |
Postes actifs de Simrat Randhawa
| Sociétés | Poste | Début |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 11/09/2023 |
Anciens postes connus de Simrat Randhawa
| Sociétés | Poste | Fin |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 01/04/2022 |
| BIOMARIN PHARMACEUTICAL INC. | Chief Tech/Sci/R&D Officer | - |
Formation de Simrat Randhawa
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Drexel University College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| AURINIA PHARMACEUTICALS INC. | Health Technology |
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
